Engineering and evaluation of precision-glycosylated clickable albumin nanoplatform for targeting the tumor microenvironment.

Saved in:
Bibliographic Details
Title: Engineering and evaluation of precision-glycosylated clickable albumin nanoplatform for targeting the tumor microenvironment.
Authors: Park JY; Department of Nuclear Medicine, Seoul National University Hospital, 03080, Seoul, Republic of Korea.; Cancer Research Institute, Seoul National University, 03080, Seoul, Republic of Korea.; Department of Nuclear Medicine, Seoul National University College of Medicine, 03080, Seoul, Republic of Korea.; Institute of Radiation Medicine, Medical Research Center, Seoul National University College of Medicine, 03080, Seoul, Republic of Korea., Choi J; Portrai Inc. Dongsullagil, 78-18, Jongno-gu, 03136, Seoul, Republic of Korea., Park J; Portrai Inc. Dongsullagil, 78-18, Jongno-gu, 03136, Seoul, Republic of Korea., Kim JS; Department of Nuclear Medicine, Seoul National University College of Medicine, 03080, Seoul, Republic of Korea., Ann YC; School of Dentistry, Seoul National University, Seoul, 03080, Republic of Korea., Chung H; Macrophage Lab, Department of Microbiology and Immunology, Seoul National University College of Medicine, Seoul 110-799, South Korea.; Institute of Endemic Diseases, Seoul National University Medical Research Center (SNUMRC), Seoul, Republic of Korea., Park J; Macrophage Lab, Department of Microbiology and Immunology, Seoul National University College of Medicine, Seoul 110-799, South Korea.; Department of Biomedical Sciences and Seoul National University College of Medicine, Seoul, Republic of Korea., Kim J; Cancer Research Institute, Seoul National University, 03080, Seoul, Republic of Korea.; Department of Nuclear Medicine, Seoul National University College of Medicine, 03080, Seoul, Republic of Korea., Seok SH; Cancer Research Institute, Seoul National University, 03080, Seoul, Republic of Korea.; Macrophage Lab, Department of Microbiology and Immunology, Seoul National University College of Medicine, Seoul 110-799, South Korea.; Institute of Endemic Diseases, Seoul National University Medical Research Center (SNUMRC), Seoul, Republic of Korea.; Department of Biomedical Sciences and Seoul National University College of Medicine, Seoul, Republic of Korea., Choi H; Department of Nuclear Medicine, Seoul National University Hospital, 03080, Seoul, Republic of Korea.; Department of Nuclear Medicine, Seoul National University College of Medicine, 03080, Seoul, Republic of Korea.; Portrai Inc. Dongsullagil, 78-18, Jongno-gu, 03136, Seoul, Republic of Korea., Im HJ; Cancer Research Institute, Seoul National University, 03080, Seoul, Republic of Korea.; Portrai Inc. Dongsullagil, 78-18, Jongno-gu, 03136, Seoul, Republic of Korea.; Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul 08826, Republic of Korea.; Department of Applied Bioengineering, Graduate School of Convergence Science and Technology, Seoul National University, Seoul 08826, Republic of Korea.; Research Institute for Convergence Science, Seoul National University, Seoul, 08826, Republic of Korea., Lee YS; Department of Nuclear Medicine, Seoul National University Hospital, 03080, Seoul, Republic of Korea.; Cancer Research Institute, Seoul National University, 03080, Seoul, Republic of Korea.; Department of Nuclear Medicine, Seoul National University College of Medicine, 03080, Seoul, Republic of Korea.; Institute of Radiation Medicine, Medical Research Center, Seoul National University College of Medicine, 03080, Seoul, Republic of Korea.; Department of Biomedical Sciences and Seoul National University College of Medicine, Seoul, Republic of Korea.
Source: Theranostics [Theranostics] 2026 Jan 01; Vol. 16 (3), pp. 1482-1503. Date of Electronic Publication: 2026 Jan 01 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Ivyspring International Publisher Country of Publication: Australia NLM ID: 101552395 Publication Model: eCollection Cited Medium: Internet ISSN: 1838-7640 (Electronic) Linking ISSN: 18387640 NLM ISO Abbreviation: Theranostics Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41355949
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Engineering and evaluation of precision-glycosylated clickable albumin nanoplatform for targeting the tumor microenvironment.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Park+JY%22">Park JY</searchLink>; Department of Nuclear Medicine, Seoul National University Hospital, 03080, Seoul, Republic of Korea.; Cancer Research Institute, Seoul National University, 03080, Seoul, Republic of Korea.; Department of Nuclear Medicine, Seoul National University College of Medicine, 03080, Seoul, Republic of Korea.; Institute of Radiation Medicine, Medical Research Center, Seoul National University College of Medicine, 03080, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Choi+J%22">Choi J</searchLink>; Portrai Inc. Dongsullagil, 78-18, Jongno-gu, 03136, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Park+J%22">Park J</searchLink>; Portrai Inc. Dongsullagil, 78-18, Jongno-gu, 03136, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+JS%22">Kim JS</searchLink>; Department of Nuclear Medicine, Seoul National University College of Medicine, 03080, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Ann+YC%22">Ann YC</searchLink>; School of Dentistry, Seoul National University, Seoul, 03080, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Chung+H%22">Chung H</searchLink>; Macrophage Lab, Department of Microbiology and Immunology, Seoul National University College of Medicine, Seoul 110-799, South Korea.; Institute of Endemic Diseases, Seoul National University Medical Research Center (SNUMRC), Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Park+J%22">Park J</searchLink>; Macrophage Lab, Department of Microbiology and Immunology, Seoul National University College of Medicine, Seoul 110-799, South Korea.; Department of Biomedical Sciences and Seoul National University College of Medicine, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+J%22">Kim J</searchLink>; Cancer Research Institute, Seoul National University, 03080, Seoul, Republic of Korea.; Department of Nuclear Medicine, Seoul National University College of Medicine, 03080, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Seok+SH%22">Seok SH</searchLink>; Cancer Research Institute, Seoul National University, 03080, Seoul, Republic of Korea.; Macrophage Lab, Department of Microbiology and Immunology, Seoul National University College of Medicine, Seoul 110-799, South Korea.; Institute of Endemic Diseases, Seoul National University Medical Research Center (SNUMRC), Seoul, Republic of Korea.; Department of Biomedical Sciences and Seoul National University College of Medicine, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Choi+H%22">Choi H</searchLink>; Department of Nuclear Medicine, Seoul National University Hospital, 03080, Seoul, Republic of Korea.; Department of Nuclear Medicine, Seoul National University College of Medicine, 03080, Seoul, Republic of Korea.; Portrai Inc. Dongsullagil, 78-18, Jongno-gu, 03136, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Im+HJ%22">Im HJ</searchLink>; Cancer Research Institute, Seoul National University, 03080, Seoul, Republic of Korea.; Portrai Inc. Dongsullagil, 78-18, Jongno-gu, 03136, Seoul, Republic of Korea.; Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul 08826, Republic of Korea.; Department of Applied Bioengineering, Graduate School of Convergence Science and Technology, Seoul National University, Seoul 08826, Republic of Korea.; Research Institute for Convergence Science, Seoul National University, Seoul, 08826, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lee+YS%22">Lee YS</searchLink>; Department of Nuclear Medicine, Seoul National University Hospital, 03080, Seoul, Republic of Korea.; Cancer Research Institute, Seoul National University, 03080, Seoul, Republic of Korea.; Department of Nuclear Medicine, Seoul National University College of Medicine, 03080, Seoul, Republic of Korea.; Institute of Radiation Medicine, Medical Research Center, Seoul National University College of Medicine, 03080, Seoul, Republic of Korea.; Department of Biomedical Sciences and Seoul National University College of Medicine, Seoul, Republic of Korea.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101552395%22">Theranostics</searchLink> [Theranostics] 2026 Jan 01; Vol. 16 (3), pp. 1482-1503. <i>Date of Electronic Publication: </i>2026 Jan 01 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Ivyspring+International+Publisher%22">Ivyspring International Publisher </searchLink><i>Country of Publication: </i>Australia <i>NLM ID: </i>101552395 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1838-7640 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2218387640%22">18387640 </searchLink><i>NLM ISO Abbreviation: </i>Theranostics <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41355949
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.7150/thno.123973
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1482
    Titles:
      – TitleFull: Engineering and evaluation of precision-glycosylated clickable albumin nanoplatform for targeting the tumor microenvironment.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Park JY
      – PersonEntity:
          Name:
            NameFull: Choi J
      – PersonEntity:
          Name:
            NameFull: Park J
      – PersonEntity:
          Name:
            NameFull: Kim JS
      – PersonEntity:
          Name:
            NameFull: Ann YC
      – PersonEntity:
          Name:
            NameFull: Chung H
      – PersonEntity:
          Name:
            NameFull: Park J
      – PersonEntity:
          Name:
            NameFull: Kim J
      – PersonEntity:
          Name:
            NameFull: Seok SH
      – PersonEntity:
          Name:
            NameFull: Choi H
      – PersonEntity:
          Name:
            NameFull: Im HJ
      – PersonEntity:
          Name:
            NameFull: Lee YS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2026 Jan 01
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1838-7640
          Numbering:
            – Type: volume
              Value: 16
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Theranostics
              Type: main
ResultId 1